位置:首页 > 蛋白库 > FOL1_PNECA
FOL1_PNECA
ID   FOL1_PNECA              Reviewed;         740 AA.
AC   P29251;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   03-AUG-2022, entry version 106.
DE   RecName: Full=Folic acid synthesis protein fol1;
DE   Includes:
DE     RecName: Full=Dihydroneopterin aldolase {ECO:0000303|PubMed:8397083};
DE              Short=DHNA {ECO:0000303|PubMed:7543066};
DE              EC=4.1.2.25 {ECO:0000269|PubMed:7950384, ECO:0000269|PubMed:8397083};
DE     AltName: Full=7,8-dihydroneopterin aldolase;
DE     AltName: Full=FasA {ECO:0000303|PubMed:8397083};
DE     AltName: Full=FasB {ECO:0000303|PubMed:8397083};
DE   Includes:
DE     RecName: Full=6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase {ECO:0000303|PubMed:8397083};
DE              Short=HPPK;
DE              EC=2.7.6.3 {ECO:0000269|PubMed:7950384, ECO:0000269|PubMed:8397083};
DE     AltName: Full=2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;
DE     AltName: Full=7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase;
DE              Short=PPPK {ECO:0000303|PubMed:7950384};
DE     AltName: Full=Dihydropterin pyrophosphokinase {ECO:0000303|PubMed:8397083};
DE     AltName: Full=FasC {ECO:0000303|PubMed:8397083};
DE   Includes:
DE     RecName: Full=Dihydropteroate synthase {ECO:0000303|PubMed:8397083};
DE              Short=DHPS {ECO:0000303|PubMed:7950384};
DE              EC=2.5.1.15 {ECO:0000269|PubMed:8397083};
DE     AltName: Full=Dihydropteroate pyrophosphorylase;
DE     AltName: Full=FasD {ECO:0000303|PubMed:8397083};
GN   Name=fol1; Synonyms=fas {ECO:0000303|PubMed:8397083};
OS   Pneumocystis carinii.
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Pneumocystidomycetes; Pneumocystidaceae; Pneumocystis.
OX   NCBI_TaxID=4754;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1313386; DOI=10.1016/0378-1119(92)90378-3;
RA   Volpes F., Dyer M., Scaife J.G., Darby G., Stammers D.K., Delves C.J.;
RT   "The multifunctional folic acid synthesis fas gene of Pneumocystis carinii
RT   appears to encode dihydropteroate synthase and hydroxymethyldihydropterin
RT   pyrophosphokinase.";
RL   Gene 112:213-218(1992).
RN   [2]
RP   PROTEIN SEQUENCE OF 1-20, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=8397083; DOI=10.1111/j.1432-1033.1993.tb18163.x;
RA   Volpe F., Ballantine S.P., Delves C.J.;
RT   "The multifunctional folic acid synthesis fas gene of Pneumocystis carinii
RT   encodes dihydroneopterin aldolase, hydroxymethyldihydropterin
RT   pyrophosphokinase and dihydropteroate synthase.";
RL   Eur. J. Biochem. 216:449-458(1993).
RN   [3]
RP   PROTEIN SEQUENCE OF 281-293, BIOPHYSICOCHEMICAL PROPERTIES, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=7950384; DOI=10.1006/prep.1994.1054;
RA   Ballantine S.P., Volpe F., Delves C.J.;
RT   "The hydroxymethyldihydropterin pyrophosphokinase domain of the
RT   multifunctional folic acid synthesis Fas protein of Pneumocystis carinii
RT   expressed as an independent enzyme in Escherichia coli: refolding and
RT   characterization of the recombinant enzyme.";
RL   Protein Expr. Purif. 5:371-378(1994).
RN   [4]
RP   CATALYTIC ACTIVITY.
RX   PubMed=7543066; DOI=10.1016/0378-1119(95)00203-i;
RA   Volpe F., Ballantine S.P., Delves C.J.;
RT   "Two domains with amino-acid sequence similarity are required for
RT   dihydroneopterin aldolase function in the multifunctional folic acid
RT   synthesis Fas protein of Pneumocystis carinii.";
RL   Gene 160:41-46(1995).
RN   [5]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF ASP-39; GLY-53; GLN-63;
RP   ASP-161; GLY-175 AND GLN-185.
RX   PubMed=9709001; DOI=10.1021/bi980540x;
RA   Thomas M.C., Ballantine S.P., Bethell S.S., Bains S., Kellam P.,
RA   Delves C.J.;
RT   "Single amino acid substitutions disrupt tetramer formation in the
RT   dihydroneopterin aldolase enzyme of Pneumocystis carinii.";
RL   Biochemistry 37:11629-11636(1998).
CC   -!- FUNCTION: Catalyzes three sequential steps of tetrahydrofolate
CC       biosynthesis. {ECO:0000269|PubMed:8397083}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7,8-dihydroneopterin = 6-hydroxymethyl-7,8-dihydropterin +
CC         glycolaldehyde; Xref=Rhea:RHEA:10540, ChEBI:CHEBI:17001,
CC         ChEBI:CHEBI:17071, ChEBI:CHEBI:44841; EC=4.1.2.25;
CC         Evidence={ECO:0000269|PubMed:7543066, ECO:0000269|PubMed:7950384,
CC         ECO:0000269|PubMed:8397083};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=6-hydroxymethyl-7,8-dihydropterin + ATP = (7,8-dihydropterin-
CC         6-yl)methyl diphosphate + AMP + H(+); Xref=Rhea:RHEA:11412,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:44841,
CC         ChEBI:CHEBI:72950, ChEBI:CHEBI:456215; EC=2.7.6.3;
CC         Evidence={ECO:0000269|PubMed:7543066, ECO:0000269|PubMed:7950384,
CC         ECO:0000269|PubMed:8397083};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(7,8-dihydropterin-6-yl)methyl diphosphate + 4-aminobenzoate =
CC         7,8-dihydropteroate + diphosphate; Xref=Rhea:RHEA:19949,
CC         ChEBI:CHEBI:17836, ChEBI:CHEBI:17839, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:72950; EC=2.5.1.15; Evidence={ECO:0000269|PubMed:7543066,
CC         ECO:0000269|PubMed:7950384, ECO:0000269|PubMed:8397083};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P0AC13};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.3 uM for 7,8-dihydroneopterin {ECO:0000269|PubMed:7950384,
CC         ECO:0000269|PubMed:9709001};
CC         KM=3.6 uM for 6-hydroxymethyl-7,8-dihydropterin
CC         {ECO:0000269|PubMed:7950384, ECO:0000269|PubMed:9709001};
CC         Vmax=36 nmol/min/mg enzyme for 7,8-dihydroneopterin
CC         {ECO:0000269|PubMed:7950384, ECO:0000269|PubMed:9709001};
CC       pH dependence:
CC         Optimum pH is 8. {ECO:0000269|PubMed:7950384,
CC         ECO:0000269|PubMed:9709001};
CC   -!- PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 2-amino-
CC       4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate from 7,8-
CC       dihydroneopterin triphosphate: step 3/4.
CC   -!- PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 2-amino-
CC       4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate from 7,8-
CC       dihydroneopterin triphosphate: step 4/4.
CC   -!- PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 7,8-
CC       dihydrofolate from 2-amino-4-hydroxy-6-hydroxymethyl-7,8-
CC       dihydropteridine diphosphate and 4-aminobenzoate: step 1/2.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the DHNA family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: In the central section; belongs to the HPPK family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the DHPS family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M86602; AAA33790.1; -; Genomic_DNA.
DR   PIR; S28666; S28666.
DR   AlphaFoldDB; P29251; -.
DR   SMR; P29251; -.
DR   SABIO-RK; P29251; -.
DR   UniPathway; UPA00077; UER00154.
DR   UniPathway; UPA00077; UER00155.
DR   UniPathway; UPA00077; UER00156.
DR   GO; GO:0003848; F:2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004150; F:dihydroneopterin aldolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004156; F:dihydropteroate synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046656; P:folic acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW.
DR   GO; GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd00534; DHNA_DHNTPE; 2.
DR   CDD; cd00739; DHPS; 1.
DR   CDD; cd00483; HPPK; 1.
DR   Gene3D; 3.20.20.20; -; 1.
DR   Gene3D; 3.30.1130.10; -; 2.
DR   Gene3D; 3.30.70.560; -; 1.
DR   InterPro; IPR045031; DHP_synth.
DR   InterPro; IPR006390; DHP_synth_dom.
DR   InterPro; IPR011005; Dihydropteroate_synth-like.
DR   InterPro; IPR006157; FolB_dom.
DR   InterPro; IPR016261; Folic_acid_synth.
DR   InterPro; IPR043133; GTP-CH-I_C/QueF.
DR   InterPro; IPR000550; Hppk.
DR   InterPro; IPR035907; Hppk_sf.
DR   InterPro; IPR000489; Pterin-binding_dom.
DR   PANTHER; PTHR20941; PTHR20941; 1.
DR   Pfam; PF02152; FolB; 2.
DR   Pfam; PF01288; HPPK; 1.
DR   Pfam; PF00809; Pterin_bind; 1.
DR   PIRSF; PIRSF000741; Folic_acid_synth; 1.
DR   SMART; SM00905; FolB; 2.
DR   SUPFAM; SSF51717; SSF51717; 1.
DR   SUPFAM; SSF55083; SSF55083; 1.
DR   TIGRFAMs; TIGR01496; DHPS; 1.
DR   TIGRFAMs; TIGR00526; folB_dom; 2.
DR   TIGRFAMs; TIGR01498; folK; 1.
DR   PROSITE; PS00792; DHPS_1; 1.
DR   PROSITE; PS00793; DHPS_2; 1.
DR   PROSITE; PS00794; HPPK; 1.
DR   PROSITE; PS50972; PTERIN_BINDING; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Direct protein sequencing; Folate biosynthesis; Kinase; Lyase;
KW   Magnesium; Metal-binding; Multifunctional enzyme; Nucleotide-binding;
KW   Transferase.
FT   CHAIN           1..740
FT                   /note="Folic acid synthesis protein fol1"
FT                   /id="PRO_0000168242"
FT   DOMAIN          471..730
FT                   /note="Pterin-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00334"
FT   REGION          39..160
FT                   /note="DHNA 1"
FT   REGION          161..280
FT                   /note="DHNA 2"
FT   REGION          291..449
FT                   /note="HPPK"
FT   REGION          473..740
FT                   /note="DHPS"
FT   BINDING         478
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P9WND1"
FT   BINDING         517
FT                   /ligand="(7,8-dihydropterin-6-yl)methyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:72950"
FT                   /evidence="ECO:0000250|UniProtKB:P0AC13"
FT   BINDING         552
FT                   /ligand="(7,8-dihydropterin-6-yl)methyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:72950"
FT                   /evidence="ECO:0000250|UniProtKB:P0AC13"
FT   BINDING         571
FT                   /ligand="(7,8-dihydropterin-6-yl)methyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:72950"
FT                   /evidence="ECO:0000250|UniProtKB:P0AC13"
FT   BINDING         643
FT                   /ligand="(7,8-dihydropterin-6-yl)methyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:72950"
FT                   /evidence="ECO:0000250|UniProtKB:P0AC13"
FT   BINDING         683
FT                   /ligand="(7,8-dihydropterin-6-yl)methyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:72950"
FT                   /evidence="ECO:0000250|UniProtKB:P0AC13"
FT   BINDING         718..720
FT                   /ligand="(7,8-dihydropterin-6-yl)methyl diphosphate"
FT                   /ligand_id="ChEBI:CHEBI:72950"
FT                   /evidence="ECO:0000250|UniProtKB:P0AC13"
FT   MUTAGEN         39
FT                   /note="D->E: Abolishes DHNA activity."
FT                   /evidence="ECO:0000269|PubMed:9709001"
FT   MUTAGEN         53
FT                   /note="G->A: Reduces DHNA activity 11-fold."
FT                   /evidence="ECO:0000269|PubMed:9709001"
FT   MUTAGEN         63
FT                   /note="Q->N: Reduces DHNA activity 16-fold."
FT                   /evidence="ECO:0000269|PubMed:9709001"
FT   MUTAGEN         161
FT                   /note="D->E: No effect."
FT                   /evidence="ECO:0000269|PubMed:9709001"
FT   MUTAGEN         175
FT                   /note="G->A: Abolishes DHNA activity."
FT                   /evidence="ECO:0000269|PubMed:9709001"
FT   MUTAGEN         185
FT                   /note="Q->N: Reduces DHNA activity 24-fold."
FT                   /evidence="ECO:0000269|PubMed:9709001"
SQ   SEQUENCE   740 AA;  83962 MW;  328F6EB91B4499EB CRC64;
     MIFKSLKIFP FYQIYGFRFL KGMIFKKKIH LSKLNKNHDL IHIHSLTLKS IVGKNSWAQR
     LLQPVVLTLS MGINASLSGN MDDLSYSIDY ATVYKEVFKL VENSKFENLL DLSDKISKVV
     LGDKCKGNWV KVIAETPKGH LLAETGLQII RRKDGIREID DQFFIKNLSL YTIIGINPEE
     RVNKQNIIID LILFKSSINL ECKDDFIINT YNIEKLLKEI VKHVEESTFK TIEALALSIA
     RISCISHNIE KIIVKVKKSC ALAFAESAGV EIVRSRSCFS SNNYIKSENS IDNEAVYISL
     GSNLGNRIKF ILDAIEKMSI KGIKVLKTSM LYESKPMYFK DQPAFYNAVC KVQTSLHPEQ
     LLFELQLIEK ELGRVKVIDK GPRCIDLDIV FYGRKIINSE SLIIPHPRVL ERSFVLKPLL
     DISGDLVHPV TGLSIASYFE KIVDHDIKPV LPFLYKNKSI DFSFRSYKAP TYIMAILNLT
     PDSFFDGGIH SYDSVLIDVE KFINAGATII DIGGQSTRPG SYIIPLEEEI FRVIPAIKYL
     QKTYPDILIS IDTFRSEVAE QAVKAGASLV NDISGGRYDP KMFNTVARLK VPICIMHMRG
     NFLNMDNLTD YGTDIIEQIT IELEKLLNSA EKSGIPRWNI ILDPGLGFSK TLHQNIELLR
     RFNELKSKNC FNGLPWLLGP SRKRFTGFIT GDNMPKDRIW GTVAAVVASI SGGCDIIRVH
     DVYEMYKISK MSDAIWKEIY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024